Delivery systems and cost recovery in Mectizan treatment for onchocerciasis.
Ann Trop Med Parasitol
; 92 Suppl 1: S23-31, 1998 Apr.
Article
en En
| MEDLINE
| ID: mdl-9861264
ABSTRACT
The efficiency of on-going delivery systems and cost recovery in Mectizan (ivermectin, MSD) treatment for onchocerciasis are reviewed. The search is on for an effective system of Mectizan delivery, involving drug procurement, delivery from port to districts and distribution to eligible persons, which can be sustained by the endemic countries for many years. The mechanisms for procuring and clearing the drug at the ports, and the drug's integration into the existing delivery systems of each national health service, need to be improved. Although large-scale treatments by mobile teams or community-based methods evidently achieve high and satisfactory rates of coverage, they also incur high recurrent costs which have to be covered by external partners and are not sustainable by national health services. Cost-sharing is considered an important factor in a sustainable delivery system and community-directed treatment, in which the community shares the cost and ownership of local distribution and is empowered to design and implement it, is likely to be more cost-effective and sustainable.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Ivermectina
/
Costos de la Atención en Salud
/
Filaricidas
/
Servicios de Salud
Tipo de estudio:
Health_economic_evaluation
Aspecto:
Determinantes_sociais_saude
Límite:
Humans
País/Región como asunto:
Africa
Idioma:
En
Revista:
Ann Trop Med Parasitol
Año:
1998
Tipo del documento:
Article
País de afiliación:
Burquina Faso